Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1803 1
1808 2
1809 1
1950 1
1966 1
1968 1
1970 1
1973 1
1979 1
1981 1
1984 6
1985 2
1986 7
1987 8
1988 10
1989 6
1990 7
1991 4
1992 6
1993 6
1994 9
1995 13
1996 7
1997 7
1998 3
1999 6
2000 4
2001 2
2002 2
2003 3
2004 6
2005 4
2006 10
2007 4
2008 3
2009 2
2010 4
2011 6
2012 7
2013 5
2014 3
2015 5
2016 7
2017 8
2018 5
2019 1
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

201 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party.
Hawkey PM, Warren RE, Livermore DM, McNulty CAM, Enoch DA, Otter JA, Wilson APR. Hawkey PM, et al. Among authors: wilson apr. J Antimicrob Chemother. 2018 Mar 1;73(suppl_3):iii2-iii78. doi: 10.1093/jac/dky027. J Antimicrob Chemother. 2018. PMID: 29514274 Review.
Sparing carbapenem usage.
Wilson APR. Wilson APR. J Antimicrob Chemother. 2017 Sep 1;72(9):2410-2417. doi: 10.1093/jac/dkx181. J Antimicrob Chemother. 2017. PMID: 28637307 Review.
Ultraviolet-C decontamination of hand-held tablet devices in the healthcare environment using the Codonics D6000™ disinfection system.
Muzslay M, Yui S, Ali S, Wilson APR. Muzslay M, et al. Among authors: wilson apr. J Hosp Infect. 2018 Nov;100(3):e60-e63. doi: 10.1016/j.jhin.2018.04.002. Epub 2018 Apr 9. J Hosp Infect. 2018. PMID: 29649557
Multidrug-resistant (MDR) Gram-negative bacteria information leaflets.
Brown C, Livermore DM, Otter JA, Warren RE, Jenks P, Enoch DA, Newsholme W, Oppenheim B, Leanord A, McNulty C, Tanner G, Bennett S, Cann M, Bostock J, Collins E, Peckitt S, Ritchie L, Fry C, Hawkey P, Wilson AP. Brown C, et al. Among authors: wilson ap. J Hosp Infect. 2016 Jan;92(1):86-7. doi: 10.1016/j.jhin.2015.08.014. J Hosp Infect. 2016. PMID: 27158703 No abstract available.
The role of the environment in the spread of healthcare associated infections.
Wilson APR. Wilson APR. J Hosp Infect. 2018 Nov;100(3):363-364. doi: 10.1016/j.jhin.2018.09.013. Epub 2018 Sep 26. J Hosp Infect. 2018. PMID: 30267741 No abstract available.
Screening for carbapenem-resistant organisms.
Wilson AP. Wilson AP. J Hosp Infect. 2016 Oct;94(2):116-7. doi: 10.1016/j.jhin.2016.07.014. Epub 2016 Jul 27. J Hosp Infect. 2016. PMID: 27520489 No abstract available.
A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis.
Wilson AP, Treasure T, Sturridge MF, Grüneberg RN. Wilson AP, et al. Lancet. 1986 Feb 8;1(8476):311-3. doi: 10.1016/s0140-6736(86)90838-x. Lancet. 1986. PMID: 2868173 Clinical Trial.
Dosage recommendations for teicoplanin.
Wilson AP, Grüneberg RN, Neu H. Wilson AP, et al. J Antimicrob Chemother. 1993 Dec;32(6):792-6. doi: 10.1093/jac/32.6.792. J Antimicrob Chemother. 1993. PMID: 8144419 Review. No abstract available.
Test parameters for efficacy evaluations of aerial hydrogen peroxide decontamination systems.
Ali S, Yui S, Muzslay M, Wilson APR. Ali S, et al. Among authors: wilson apr. J Hosp Infect. 2018 Apr;98(4):438-439. doi: 10.1016/j.jhin.2017.09.011. Epub 2017 Sep 18. J Hosp Infect. 2018. PMID: 28923374 No abstract available.
Clinical pharmacokinetics of teicoplanin.
Wilson AP. Wilson AP. Clin Pharmacokinet. 2000 Sep;39(3):167-83. doi: 10.2165/00003088-200039030-00001. Clin Pharmacokinet. 2000. PMID: 11020133 Review.
201 results
Jump to page
Feedback